Genmab — November 2017

[E_L]

sort of expected after the advisory committee adviced this last month. usefull read of the pdf if you understand dutch...

[StockBull]

OK, whats the base - One could then think its added to the next insurance level (above the base)

[E_L]

they sort of indicate DarBorDex needs to drop 30% in price, DarLenDex 70% to get into the cost effectiveness range...

[E_L]

'" relevant is also that part of the extra cost of DarLenDex are that treatment is longer" . No shit Sherlock... It works , so patients live longer, so you have to pay longer... who would have thought...

[StockBull]

OK, so how will the treat the people with MM ? I understand Darzalex are price competitive compared to other treatment options

[Sukkeralf]

With LenDex or BorDex

[E_L]

and this will be used by the ministry of health to negotiate with JNJ. The letter asks parties to do this as fast as possible in the interest of patients and in the mean time they ask the manufacturer to provide Dara at the cost of the manufacturer...

[GeorgeBest]

Are the Dutch the European mainland Scottish? Why not give it for free?

[E_L]

yeah... NL is a nice market, with good health care, but i believe it is too small for JNJ to set a precedent by dropping prices too much... Let's hope negotiations go fast

[StockBull]

NL healte ministry are doing what they have to do - it would be stupid not to try negotiate a better price

[rex_pacis]

Sure, but I wonder why NL should not pay the same as other countries

[StockBull]

eventually they will have to come to some kind of agreement

[StockBull]

true - maybe its just politic - looks stupid in the public if they do not try to negotiate something better

[StockBull]

or maybe they dont have any money on 2017 budget

[Sukkeralf]

Lidt bekymrende at vi falder så meget tilbage i dag - NBI vendte i går rundt fra minus til plus, så det burde i princippet give lidt ekstra til Genmab.

[Nickstar]

Synes det har været bekymrende i månedsvis. Den ligger i samme niveau som slut maj sidste år. Halvandet år uden at komme videre op.

[Helge_LarsenPI-redaktør]

Det hele drejer sig vel bare om,at større investorer mener at de kan finde bedre afkastmuligheder på kort- eller mellemlang sigt end de kan i Genmab. Den slags er jo helt almindeligt forekommende i de fleste udviklingsselskabers historik.

[Raun]

I går så vi samme faldende tendens, først på dagen.... Mener de va ved 11-12 tiden at aktien begyndte den pludselige stigning, med øget omsætning..... Hvis det er luk af shots, skulle vi gerne se samme mønster i dag...

[Nickstar]

men man ka så tænke over hvorfor de større investorer trækker sig pga de mener at ku få bedre afkast andetsteds. ska der det næsten utænkelige til for at drive kursen op, nu da meget allerede er indregnet, og forventninger ultra høje

[Nickstar]

og risikoen for stor ift fald på selv små skuffelser?